Asia Pacific Infoserv, Feb 2012, Pages: 310
The Indianpharmaceuticalindustry is undergoing fast paced changes. The Indian generics market is witnessing rapid growth opening up immense opportunities for firms. This is further triggered
Digital Vector, April 2007, Pages: 325
Indianpharmaceuticalindustry is undergoing fast paced changes. The Indian Generics market is witnessing rapid growth opening up immense opportunities for firms. This is further triggered
Credit Analysis & Research Limited, Dec 2011, Pages: 133
The IndianPharmaceuticalIndustry (IPI) is the 3rd largest in the world in terms of volume and 14th largest in terms of value. It has been growing at a healthy rate of 15% CAGR over the last 5
Espicom Business Intelligence Ltd, June 2010, Pages: 248
review of the Indian market and the 18 companies that are leading the way. The IndianPharmaceuticalIndustry: New Strategies in a Changing World
Digital Vector, Oct 2005, Pages: 320
pharmaceuticalindustry is undergoing fast paced changes. The Indian Generics market is witnessing rapid growth opening up immense opportunities for firms. This is further triggered by the fact that generics worth
JZMed Inc., May 2011, Pages: 230
industry between China and India
1. Chinese pharmaceuticalindustry
2. Indianpharmaceuticalindustry
3.2.4 Comparison of drug R&D capability between China and India
3.2.5 Comparison of biotech industry
VOI Consulting, Inc., March 2009, Pages: 500
Copayments by Tier 2000-06
Figure 4 - Distribution of Rx Bene? ts in Population over 65 (July 2006)
Figure 6 - Changes in Source of Payment for Retail Prescriptions
Figure 7 - Sales by Channel 2005
Figure
Netscribes (India) Pvt. Ltd., Oct 2011, Pages: 42
products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government
CYGNUS Business Consulting & Research, Oct 2010, Pages: 176
and Divis.
Indian bulk drugs industry is undergoing rapid changes since the past few years, especially with the introduction of patent regime. The narrowing down of research pipelines, the growing pricing
IKON Marketing Consultants, Sep 2011, Pages: 50
10 global player by 2015 itself. Looking at the immense potential IndianPharmaceuticalindustry have, IKON estimates that the current decade will be going to change the prescription in Indian
Global Industry Analysts, Inc., Feb 2010, Pages: 893
PharmaceuticalIndustries Limited
- The Medicines Company.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select
Global Industry Analysts, Inc., Oct 2010, Pages: 565
into Agreement 117
Bausch & Lomb Enters into Marketing Agreement with Novartis 117
Santen Pharmaceuticals and Ube Industries to Develop Glaucoma
Therapy Jointly
Markets and Markets, April 2010, Pages: 118
a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus
Datamonitor, Aug 2010, Pages: 167
- Prescriptionpharmaceutical sales
Publications and online articles
Brazil - Drug expiry analysis
Publications and online articles
Datamonitor reports and products
Brazil - Pharmaceuticalindustry
Business Monitor International, March 2010, Pages: 87
Saudi Arabia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
Business Monitor International, Oct 2009, Pages: 100
The India Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
Aruvian's R'search, March 2008, Pages: 30
The IndianPharmaceuticalIndustry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly
CYGNUS Business Consulting & Research, Sep 2011, Pages: 304
In view of the growth potential and India's strength in pharmaceuticals to qualify for clinical trials, Cygnus has launched the latest edition (7th edition) of Industry Insight – Clinical Trials
Global Industry Analysts, Inc., Oct 2010, Pages: 507
., Conceptus, Inc., Condomi Health International GmbH, Female Health Company, Fuji Latex Co Ltd., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceutical Inc., Merck & Co., Inc., Okamoto Industries, Inc., SSL
